Učitavanje...
Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia
Current objectives regarding treatment of acute myeloid leukemia (AML) include achieving complete remission (CR) by clinicopathological criteria followed by interrogation for the presence of minimal/measurable residual disease (MRD) by molecular genetic and/or flow cytometric techniques. Although ad...
Spremljeno u:
| Izdano u: | Blood |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225688/ https://ncbi.nlm.nih.gov/pubmed/32232484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004770 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|